Found 7 matching trials
Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial NA Study Objective To compare the efficacy of continued scheduled dosing versu...
Show More Location
The Second Affiliated Hospital of Zhejiang Chinese Medical University
Learn More & Join Trial
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease PHASE2 This study evaluates the efficacy and safety of the addition of Firsekibart...
Show More Location
Jiangxi Provincial Children's Hospital
Learn More & Join Trial
Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis NA This study is a single-center, single-arm, open-label, exploratory clinical...
Show More Location
Tongji Hospital, Tong ji Medical Colledge
Learn More & Join Trial
A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease N/A The purpose of this study is to compare the efficacy and safety of firsekib...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus PHASE4 Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder in whi...
Show More Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Learn More & Join Trial
24-Week Recurrence Rate of Gout Following Firsekibart Treatment NA Study Objective: To evaluate the 24-week recurrence rate and safety of Firs...
Show More Location
Fuzhou University Affiliated Provincial Hospital
Learn More & Join Trial
A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma NA This study aims to evaluate the effectiveness and safety of a combination t...
Show More Location
Multiple Locations
Learn More & Join Trial